|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q60311020
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241020233035.0 |
|
008
|
|
|
241020nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q60311020
|
|
024
|
|
|
‡a
0000-0001-6486-1086
‡2
orcid
|
|
024
|
|
|
‡a
18037584900
‡2
scopus
|
|
024
|
|
|
‡a
56346357300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q60311020
|
|
100
|
0 |
|
‡a
Erika Aurora Martínez-García
‡c
researcher ORCID ID = 0000-0001-6486-1086
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Erika Aurora Martínez-García
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
|
|
670
|
|
|
‡a
Author's Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis.
|
|
670
|
|
|
‡a
Author's Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice
|
|
670
|
|
|
‡a
Author's Genotype Ser413/Ser ofPAI‐2 polymorphism Ser413/Cys is associated with anti‐phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls
|
|
670
|
|
|
‡a
Author's Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies
|
|
670
|
|
|
‡a
Author's IL-17 Increased in the Third Trimester in Healthy Women with Term Labor
|
|
670
|
|
|
‡a
Author's Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells.
|
|
670
|
|
|
‡a
Author's Leptin as an open secret in the physiopathology of rheumatic diseases
|
|
670
|
|
|
‡a
Author's Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.
|
|
670
|
|
|
‡a
Author's Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis
|
|
670
|
|
|
‡a
Author's Potential Chronotherapeutic Optimization of Antimalarials in Systemic Lupus Erythematosus: Is Toll-Like Receptor 9 Expression Dependent on the Circadian Cycle in Humans?
|
|
670
|
|
|
‡a
Author's Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis
|
|
670
|
|
|
‡a
Author's The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study
|
|
670
|
|
|
‡a
Author's The clinical significance of posttranslational modification of autoantigens
|
|
670
|
|
|
‡a
Author's The Distribution of CD56dimCD16+ and CD56brightCD16− Cells are Associated with Prolactin Levels during Pregnancy and Menstrual Cycle in Healthy Women
|
|
670
|
|
|
‡a
Author's The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane
|
|
909
|
|
|
‡a
(scopus) 18037584900
‡9
1
|
|
909
|
|
|
‡a
(scopus) 56346357300
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000164861086
‡9
1
|
|
919
|
|
|
‡a
lowlevelsofcd36inperipheralbloodmonocytesinsubclinicalatherosclerosisinrheumatoidarthritisacrosssectionalstudyinamexicanpopulation
‡A
Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.
‡9
1
|
|
919
|
|
|
‡a
polymorphismrs2073618ofthetnfrsf11bopggeneandbonemineraldensityinmexicanwomenwithrheumatoidarthritis
‡A
Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis
‡9
1
|
|
919
|
|
|
‡a
inhibitorsofmapkpathwayerk12orp38preventtheil1betainducedupregulationofsrp72autoantigeninjurkatcells
‡A
Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells.
‡9
1
|
|
919
|
|
|
‡a
17increasedinthe3trimesterinhealthywomenwithtermlabor
‡A
IL-17 Increased in the Third Trimester in Healthy Women with Term Labor
‡9
1
|
|
919
|
|
|
‡a
goodresponsetomycophenolatemofetilontreatmentofinterstitiallungdiseaseinpolymyositisassociatedwithantisynthetasesyndromepositiveforantiejandantiro52antibodies
‡A
Good response to mycophenolate mofetil on treatment of interstitial lung disease in polymyositis associated with antisynthetase syndrome positive for anti-EJ and anti-Ro52 antibodies
‡9
1
|
|
919
|
|
|
‡a
genotypeser413serofpai2polymorphismser413cysisassociatedwithantiphospholipidsyndromeandsystemiclupuserythematosusinafamilialcasecomparisonwithhealthycontrols
‡A
Genotype Ser413/Ser ofPAI‐2 polymorphism Ser413/Cys is associated with anti‐phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls
‡9
1
|
|
919
|
|
|
‡a
downregulationofhippocampalnr2a2bsubunitsrelatedtocognitiveimpairmentinapristaneinducedlupusbalb100mice
‡A
Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice
‡9
1
|
|
919
|
|
|
‡a
associationbetweenboneturnovermarkersclinicalvariablesspinalsyndesmophytesandbonemineraldensityinmexicanpatientswithankylosingspondylitis
‡A
Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis.
‡9
1
|
|
919
|
|
|
‡a
anticycliccitrullinatedpeptideantibodiesandseverityofinterstitiallungdiseaseinwomenwithrheumatoidarthritis
‡A
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
‡9
1
|
|
919
|
|
|
‡a
potentialchronotherapeuticoptimizationofantimalarialsinsystemiclupuserythematosusistolllikereceptor9expressiondependentonthecircadiancycleinhumans
‡A
Potential Chronotherapeutic Optimization of Antimalarials in Systemic Lupus Erythematosus: Is Toll-Like Receptor 9 Expression Dependent on the Circadian Cycle in Humans?
‡9
1
|
|
919
|
|
|
‡a
serumlevelsofanticycliccitrullinatedpeptideantibodiesinterleukin6tumornecrosisfactorαand100reactiveproteinareassociatedwithincreasedcarotidintimamediathicknessacrosssectionalanalysisofacohortofrheumatoidarthritis
‡A
Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis
‡9
1
|
|
919
|
|
|
‡a
174g100and572g100interleukin6promotergenepolymorphismsinmexicanpatientswithrheumatoidarthritisacasecontrolstudy
‡A
The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study
‡9
1
|
|
919
|
|
|
‡a
clinicalsignificanceofposttranslationalmodificationofautoantigens
‡A
The clinical significance of posttranslational modification of autoantigens
‡9
1
|
|
919
|
|
|
‡a
distributionofcd56dimcd16+andcd56brightcd16cellsareassociatedwithprolactinlevelsduringpregnancyandmenstrualcycleinhealthywomen
‡A
The Distribution of CD56dimCD16+ and CD56brightCD16− Cells are Associated with Prolactin Levels during Pregnancy and Menstrual Cycle in Healthy Women
‡9
1
|
|
919
|
|
|
‡a
dnacovaccinationusingsmantigenandil10asprophylacticexperimentaltherapyamelioratesnephritisinamodeloflupusinducedbypristane
‡A
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane
‡9
1
|
|
919
|
|
|
‡a
leptinasanopensecretinthephysiopathologyofrheumaticdiseases
‡A
Leptin as an open secret in the physiopathology of rheumatic diseases
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
LC|no2011098995
|
|
996
|
|
|
‡2
PLWABN|9810620028105606
|
|
996
|
|
|
‡2
ISNI|0000000024445128
|
|
996
|
|
|
‡2
DNB|133987140
|
|
996
|
|
|
‡2
NTA|071033858
|
|
996
|
|
|
‡2
LC|ns2020000936
|
|
996
|
|
|
‡2
LC|no2004066497
|
|
996
|
|
|
‡2
J9U|987012502991705171
|
|
996
|
|
|
‡2
LC|ns2016003634
|
|
996
|
|
|
‡2
ISNI|0000000389477261
|
|
996
|
|
|
‡2
J9U|987007290102505171
|
|
996
|
|
|
‡2
LC|no2022110707
|
|
996
|
|
|
‡2
ISNI|0000000116174396
|
|
996
|
|
|
‡2
LC|n 2020182514
|
|
996
|
|
|
‡2
LC|ns2014000485
|
|
996
|
|
|
‡2
DNB|17211196X
|
|
996
|
|
|
‡2
DNB|1196028036
|
|
996
|
|
|
‡2
ISNI|0000000495486364
|
|
996
|
|
|
‡2
SUDOC|200428705
|
|
996
|
|
|
‡2
SUDOC|197361226
|
|
996
|
|
|
‡2
NTA|119081199
|
|
996
|
|
|
‡2
RERO|A003279493
|
|
996
|
|
|
‡2
LC|no2023131256
|
|
996
|
|
|
‡2
LC|ns2024000640
|
|
996
|
|
|
‡2
NUKAT|n 2016235963
|
|
996
|
|
|
‡2
NII|DA18324862
|
|
996
|
|
|
‡2
BLBNB|000215001
|
|
996
|
|
|
‡2
NSK|000016953
|
|
996
|
|
|
‡2
ISNI|0000000032334479
|
|
996
|
|
|
‡2
ISNI|0000000066385960
|
|
996
|
|
|
‡2
SUDOC|161363261
|
|
996
|
|
|
‡2
PLWABN|9810644881005606
|
|
996
|
|
|
‡2
DNB|1290894329
|
|
996
|
|
|
‡2
LC|no2009073914
|
|
996
|
|
|
‡2
LC|ns2016003052
|
|
996
|
|
|
‡2
BIBSYS|90122967
|
|
996
|
|
|
‡2
SUDOC|08191895X
|
|
996
|
|
|
‡2
J9U|987007398275605171
|
|
996
|
|
|
‡2
LC|ns2023000669
|
|
996
|
|
|
‡2
NII|DA14823565
|
|
996
|
|
|
‡2
LC|n 80054082
|
|
996
|
|
|
‡2
DNB|1222137984
|
|
996
|
|
|
‡2
ISNI|0000000496685533
|
|
996
|
|
|
‡2
LC|ns2017002341
|
|
996
|
|
|
‡2
BNF|12862685
|
|
996
|
|
|
‡2
NUKAT|n 2006143780
|
|
996
|
|
|
‡2
DNB|139599436
|
|
996
|
|
|
‡2
SUDOC|24230110X
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
